Navigation Links
Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
Date:10/28/2009

lication.

"These data indicate that the TRANA Discovery assay has identified a number of compounds with modest antiviral activity against HIV-1," said Roger Ptak, Co-Principal Investigator, Southern Research Institute, in his report to the Division of Acquired Immunodeficiency Syndrome (DAIDS) within NIAID. "Additional testing of compounds with similar structures, as well as broader HTS, should lead to the identification of lead compounds that inhibit HIV-1 replication through the novel mechanism of inhibiting the interaction between tRNALys3 and viral genomic RNA."

As a result of this successful pilot study, DAIDS has approved $700,000 of additional funding for the contract with Southern Research Institute in order to screen an additional 300,000 compounds and to conduct confirmatory testing of selected lead compounds. Lead candidates (or analogs) identified through this screening will be pursued by Trana Discovery for development and to secure the property rights and patents as deemed appropriate.

Toward that end, Trana Discovery is seeking organizations interested in licensing identified leads or that hold diverse collections of compounds or compounds with known bioactivity against HIV but unknown mechanism of action to identify candidates for drug development.

The use of high-throughput screening (HTS) assays developed by Trana Discovery can provide licensing opportunities for exclusive rights to new drug classes and reduce the cost and time for drug discovery.

"We are excited about the results from the initial screening efforts and for the confidence exhibited by the NIAID/DAIDS by this additional funding commitment," said Steve Peterson, CEO of Trana Discovery. "We remain very optimistic that the use of our HIV assay will lead to new antivirals for the treatment of this disease."

NIAID conducts and supports research to stu
'/>"/>

SOURCE Southern Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
2. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
3. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
4. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
5. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
6. Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
7. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
8. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
9. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
10. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
11. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "2015 Strategies in ... offering. This new 175-page report provides ... including diabetes (strips and meters), pregnancy, ovulation, and ... growth, regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Technologies, Inc. (NYSE Amex: PTN ) today announced ... Palatin,s request to begin a Phase 2A proof-of-concept human trial ... administered formulation of PL-3994, an NPR-A agonist compound, in development ... "We are excited about the prospect of advancing PL-3994 into ...
... 3, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... preventive vaccines against cancers and infectious diseases, announced today that ... company overview at the ROTH 23rd Annual Growth Stock Conference ... A live and archived webcast will be accessible ...
Cached Medicine Technology:FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for Asthma 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 3
(Date:7/1/2015)... , ... July 01, 2015 , ... Incentivizing the use ... under control, with discounts as much as 80% or 90% off the prices for ... insurers need to act to mitigate the financial impact of these high-cost generic drugs. ...
(Date:7/1/2015)... ... ... The Recovery Workforce Summit: 2015 PRA Annual Conference , presented by ... as a keynote on June 2nd in Philadelphia, PA. Stossel led a timely keynote ... power and reach to the essential message, while opening doors to wellness and recovery. ...
(Date:7/1/2015)... ... July 01, 2015 , ... The executive ... and marketing of a number of nutritional and beauty products, announced the company ... ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This specific ECRM ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers protection ... to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor and ... Thule owners have come to expect. , The Thule Atmos X4 has ...
(Date:7/1/2015)... ... 01, 2015 , ... AvePoint, the established leader ... a new operational office in Zurich, Switzerland. The new facility will deliver enterprise-level ... business for organizations throughout the Swiss market. , “AvePoint is committed to ...
Breaking Medicine News(10 mins):Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3
... Retinoic Acid and Clindamycin Products Developed with ... Skinvisible, Inc. (OTC,Bulletin Board: SKVI) ( http://www.skinvisible.com ... formulating enhanced patented dermatology,products, announced it has ... Co. Ltd. ("Embil"). The Agreement is for ...
... National,Business Group on Health, a national non-profit organization ... commitment and,dedication to promoting a healthy workplace and ... Sanofi-aventis U.S. was among 52 employers that ... the Leadership Summit sponsored,by the National Business Group ...
... leader Scott Sarran embraces health and,wellness, CHICAGO, ... named vice president and chief medical officer for ... seasoned physician executive with expertise,in group practice leadership ... responsible for overall medical leadership; setting strategy for ...
... Individuals with autism spectrum disorders (ASD) show profound ... repetitive behaviors and abnormal responses to sensory experiences. ... social abilities is their lack of affiliative behaviors, ... strengthen social bonds. On May 15th, Biological ...
... Fifth Year to Give Away 20,000 ... SHERMAN OAKS, Calif., May 13 The Sunkist Take a,Stand(R) ... ever. This year,Sunkist Growers, with proud supporters Rubbermaid(R) and Domino(R)/C&H(R),Sugar, ... lemonade stands to kids who pledge to raise money for ...
... BIOCOM, the association for the,Southern California life ... portfolio with four new agreements with PR,Newswire, Innovative ... list of BIOCOM-preferred vendors who discount their goods ... agreements will provide BIOCOM members with special,rates on ...
Cached Medicine News:Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 2Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 3Health News:Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health 2Health News:Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health 3Health News:Blue Cross and Blue Shield of Illinois Names New Chief Medical Officer 2Health News:Genetic links to impaired social behavior in autism 2Health News:Kids Squeeze 'Aid' Out of Lemons as Take a Stand(R) Program Launches Nationwide 2Health News:Kids Squeeze 'Aid' Out of Lemons as Take a Stand(R) Program Launches Nationwide 3Health News:BIOCOM Purchasing Group Brings in Four New Contracts 2Health News:BIOCOM Purchasing Group Brings in Four New Contracts 3Health News:BIOCOM Purchasing Group Brings in Four New Contracts 4
Straight shafts with 1 x 2 teeth. Serrated handle with polished finish. Delicate teeth....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: